v3.24.2.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:        
Net loss $ (2,469) $ (3,707) $ (5,458) $ (7,049)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization expense     4,189 4,256
Amortization of loan costs     384 759
Gain on settlement of liability     (295) 0
Loss on interest rate cap     55 0
Loss (gain) on sale of real estate 0 0 42 (660)
Equity based payment     3,409 2,566
Impairment 0 0 157 0
Change in fair value of Earn-Out liability (310) (0) (964) (0)
Changes in operating assets and liabilities        
Due to/from related parties     (18) 156
Accounts payable and accrued expenses     (1,566) 378
Other assets     459 486
Deferred offering costs     0 (3,022)
Accounts receivable     (1,405) (91)
Net cash (used in) operating activities     (1,011) (2,221)
Cash flows from investing activities:        
Capital expenditures     (351) (1,098)
Capitalized technology     0 (23)
(Payments) proceeds on sale of investment in real estate     (155) 1,475
Net cash (used in) provided by investing activities     (506) 354
Cash flows from financing activities:        
Payments on notes payable     (7,084) (2,609)
Proceeds from notes payable     5,900 0
Distributions to non-controlling interest holders     (92) (325)
Loan fees     (604) 0
Net cash (used in) financing activities     (1,880) (2,934)
Net change in cash and cash equivalents and restricted cash     (3,397) (4,801)
Cash and cash equivalents and restricted cash, beginning of period     16,711 10,974
Cash and cash equivalents and restricted cash, end of period 13,314 6,173 13,314 6,173
Reconciliation of Cash and Cash Equivalents and Restricted Cash:        
Cash and cash equivalents at beginning of period     11,134 5,758
Restricted cash at beginning of period     5,577 5,216
Cash and cash equivalents and restricted cash, beginning of period     16,711 10,974
Cash and cash equivalents at end of period 8,690 2,029 8,690 2,029
Restricted cash at end of period 4,624 4,144 4,624 4,144
Cash and cash equivalents and restricted cash, end of period 13,314 6,173 13,314 6,173
Supplemental disclosures of cash flow information:        
Interest Paid     5,721 6,102
Non-cash investing and financing activities:        
Dividends declared not yet paid 1,014 1,500 1,014 1,500
Accrued preferred distributions paid in common stock     1,613 0
Right of use asset obtained in exchange for lease obligation     332 0
Note receivable related to disposition of property $ 3,120 $ 0 $ 3,120 $ 0
Equity shares issued in exchange for accrued compensation (in shares)     1,301 0
Accrued capital expenditures     $ 16 $ 503

Source